Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Motherhood With MOtor Impairment Due to MAlady (Rare Disease) (MMOMA)

25. Mai 2018 aktualisiert von: Assistance Publique - Hôpitaux de Paris

Parenthood and Motherhood in Women With Motor Impairment and Disability Related to a Rare Disease

Background Women with rare diseases resulting in motor disabilities wishing to become mother face a major challenge. The investigators hypothesize that provided with adequate support, they are able to achieve a successful pregnancy and to offer their child a safe family environment.

Methods To test this hypothesis, the investigators shall conduct a prospective observational prospective survey of a consecutive series of volunteer pregnant women or mothers of children less than 14 months, with motor impairment, participating in a program of parenting support developed in our institution.

Primary outcome: social environment, child development, mother-infant attachment, mother- infant interactions Secondary outcome: social and demographic characteristics, severity of motor impairment, associated impairment, perinatal morbidity for the mother and the infant (composite indicator), emotional status, and the needs expressed by women regarding the level of medical or social care.

Analysis The investigators shall describe the distribution of the primary outcome measurements in the subgroup of women with motor impairment related to a rare disease. The investigators shall compare this distribution to the expected distribution in the general population, and to that observed in women with motor impairment unrelated to a rare disease. The investigators shall also study primary outcome measurements as a function of the severity of maternal disability, of the mother's social characteristics and emotional status.

The investigators shall also describe the distribution the distribution of perinatal morbidity globally, and as a function of the potential explanatory variables mentioned above.

The investigators shall also report on the opinion of women regarding the support they were offered so far, and the support they declare they should benefit from.

Studienübersicht

Status

Abgeschlossen

Detaillierte Beschreibung

Background Women with motor disabilities have the same well-founded desire to become a mother as other women. Despite dedicated aids and adapted supportive measures, they face social blame from persons who believe they are not apt to provide adequate care to their children. When a rare disease caused the disability, planning to become a mother is even more critical, since most perinatal care providers are unfamiliar with the condition, and specialists of the disease are unfamiliar with pregnancy. Unsurprisingly, data on motherhood in women with rare diseases resulting in motor impairment are scarce.

The institutions of the investigators run a joint care program dedicated to future parents and parents with disabilities, namely:

  • Hôpital Universitaire Pitié Salpêtrière- Charles Foix (assistance Publique Hôpitaux de Paris and Université Paris 6), providing a gynecological and perinatal unit with care programs adapted to women with disabilities, plus a number of reference centers for rare neurologic and muscular diseases including research and clinical care.
  • Service d'Aide à la Parentalité des Personnes en Situation de Handicap (SAPPH, Fondation Hospitalière Sainte Marie) providing training and support to parenthood to persons with motor or sensory disabilities. This training program aims at recognizing parental capacities, and if necessary enhancing them by information, training, adapting the environment, or seeking extra human help.

The investigators felt the need to evaluate the outcome of our program, in terms of quality of infant environment, development, attachment, and interactions with their disabled mother. The investigators focused on parenthood in women with a rare disease resulting in motor impairment, a research field remaining largely unexplored so far.

Hypothesis Our hypothesis is that when provided with a specific care program, mothers with motor impairment due to a rare disease and their partners have the capacity to offer their children appropriate social environment and care, resulting in child development, mother-infant attachment, and mother- infant interactions being similar to what one would expect in women without motor impairment.

Objective Primary objective To describe social environment, child development, mother-infant attachment, mother- infant interactions, when the mother has motor impairment due du a rare disease.

Secondary objective

  1. To describe maternal and perinatal outcome when the mother has motor impairment due du a rare disease
  2. To explore a potential relation between the outcome criteria of the primary goal with

    • The severity of motor impairment
    • The causal disease
    • The personal history of the mother including her access to adapted care prior to pregnancy during pregnancy and post-partum
    • The social status of the family
    • The emotional status of the mother
  3. To compare the distribution of primary goal outcome criteria in our study population to what is expected in the general population, when appropriate
  4. To compare the distribution of primary goal outcome criteria in our study population to what we observed in women with motor impairment that does not result from a rare disease
  5. To describe the needs expressed by women regarding medical care, psychological, social, and environmental support

Eligibility criteria Please see specific box

Outcome measurements (assessed at least once before the age of 14 months, see specific box) Primary outcome Child development /Infant attachment /Social environment /Mother infant interaction/ Child protection legal decisions if applicable Secondary outcome Demographic and social characteristics Disease or event causing impairment Obstetrical history Somatic and psychic events before, during pregnancy, and post-partum History of access to care Severity of impairment and handicap Maternal emotional status Needs expressed by women regarding medical care, psychological, social, and environmental support

Study design Pre inclusion: written and verbal information on the study to all women with motor impairment seeking care either at the Pitié Salpétrière Maternity unit or at the Service d'Aide à la Parentalité pour les Personnes en Situation de Handicap (SAPPH) Inclusion visit: During a planned training session, either pre natal or post natal Follow up visit: once of twice before the child is 14 months. A specific consent of both parents will be required for all outcome criteria concerning the infant.

Research visits will take place during usual visits of our parenthood support and training program.

Analysis The investigators shall describe the distribution of the primary outcome measurements in the subgroup of women with motor impairment related to a rare disease. The investigators shall compare this distribution to the expected distribution in the general population, and to that observed in women with motor impairment unrelated to a rare disease. The investigators shall also study primary outcome measurements as a function of the severity of maternal disability, of the mother's social characteristics and emotional status.

The investigators shall also describe the distribution the distribution of perinatal morbidity globally, and as a function of the potential explanatory variables mentioned above.

the investigators shall also report on the opinion of women regarding the support they were offered so far, and the support they declare they should benefit from.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

29

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Weiblich

Probenahmeverfahren

Nicht-Wahrscheinlichkeitsprobe

Studienpopulation

Pregnant women or mothers to children < 14 months, with motor impairment, visiting the inclusion center and willing to participate in the study. Any motor impairment available, regardless of its cause.

Beschreibung

Inclusion Criteria:

  • Women aged 18 or older
  • Either pregnant > 14 weeks, or mother of a child < 1 year
  • With disability resulting from motor impairment
  • Giving informed consent
  • With social insurance

Exclusion Criteria:

  • Know mental retardation
  • Known psychiatric disorder
  • Not fluent in French

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
mothers with motor impairment due to a rare disease
20 Women with motor impairment due to a rare disease
mothers with motor impairment not related to a rare disease
controls, 20 women with motor impairment not related to a rare disease

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Child development Mother infant attachment - Coding Interactive Behavior - Pirgas scale - Child protection legal decisions if applicable
Zeitfenster: At least once before the age of 14 months. May be repeated twice.
Child development assessed by Brunet Lézine score: based on standardized examination of the infant by a trained child psychologist
At least once before the age of 14 months. May be repeated twice.
Infant attachment
Zeitfenster: At least once before the age of 14 months. May be repeated twice.
Infant attachment assessed by Guedenet and Fermanian ADBB scale: scale assessed by investigator
At least once before the age of 14 months. May be repeated twice.
Social environment
Zeitfenster: At least once before the age of 14 months. May be repeated twice.
Social environment assessed by Cutrona scale: self-administered questionnaire
At least once before the age of 14 months. May be repeated twice.
Mother infant interaction
Zeitfenster: At least once before the age of 14 months. May be repeated twice.

assessed by:

  • Coding Interactive Behavior: mother infant interaction filmed in a standardized fashion, and analyzed by trained psychologists blinded to the dyad's history.
  • Pirgas scale: clinical diagnosis regarding mother to infant interactions Child protection legal decisions : type of decision if applicable.
At least once before the age of 14 months. May be repeated twice.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Demographic and social characteristics
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
Demographic and social characteristics, qualitative variables (Questionnaire administered by investigator)
At lest once before the age of 14 months. May be repeated twice.
Epices score of social deprivation
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
Epices score of social deprivation (Self-administered questionnaire)
At lest once before the age of 14 months. May be repeated twice.
Disease or event causing impairment
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
Disease or event causing impairment: preset qualitative variables (Questionnaire administered by investigator)
At lest once before the age of 14 months. May be repeated twice.
Obstetrical history
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
Obstetrical history: preset qualitative variables (Questionnaire administered by investigator)
At lest once before the age of 14 months. May be repeated twice.
Somatic and psychic events before, during pregnancy, and post-partum (composite scores)
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
At lest once before the age of 14 months. May be repeated twice.
History of access to care
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
History of access to care: standardized interview (Questionnaire administered by investigator)
At lest once before the age of 14 months. May be repeated twice.
Barthel score of capacity in everyday life
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
Barthel score of capacity in everyday life (Self-administered questionnaire)
At lest once before the age of 14 months. May be repeated twice.
Ad hoc ordinal score based on the number of body parts with motor impairment and additional non-motor impairment
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
At lest once before the age of 14 months. May be repeated twice.
Maternal emotional status
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
Assessed by STAI / EPDS scales (Self-administered questionnaire)
At lest once before the age of 14 months. May be repeated twice.
List of the needs expressed by women regarding medical care, psychological, social, and environmental support
Zeitfenster: At lest once before the age of 14 months. May be repeated twice.
Assessed self-administered questionnaire
At lest once before the age of 14 months. May be repeated twice.

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

2. März 2016

Primärer Abschluss (Tatsächlich)

28. August 2017

Studienabschluss (Tatsächlich)

28. November 2017

Studienanmeldedaten

Zuerst eingereicht

29. März 2016

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

29. März 2016

Zuerst gepostet (Schätzen)

4. April 2016

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

29. Mai 2018

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

25. Mai 2018

Zuletzt verifiziert

1. Dezember 2016

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Klinische Studien zur Bewertung der Behinderung

3
Abonnieren